Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants

Significant advances have been achieved in the outcomes of patients with myelodysplastic syndromes (MDS) after both HLA-matched sibling donor transplants (MSDT) and non-MSDT, the latter including HLA-matched unrelated donor (MUDT) and haplo-identical donor transplants (HIDT). In this retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hong, Liu, Hong, Zhou, Jin-Yi, Zhang, Tong-Tong, Jin, Song, Zhang, Xiang, Chen, Su-Ning, Li, Wei-Yang, Xu, Yang, Miao, Miao, Wu, De-Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337979/
https://www.ncbi.nlm.nih.gov/pubmed/28262717
http://dx.doi.org/10.1038/srep43488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337979/
https://www.ncbi.nlm.nih.gov/pubmed/28262717
http://dx.doi.org/10.1038/srep43488

Ejemplares similares